RelA/p65 Regulation of IκBβ

REFERENCES

• Amit, S., and Y. Ben-Neriah. 2003. NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin. Cancer Biol. 13:15–28.
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos, F., J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. 1995. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15:2689–2696.
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos, F., P. Turpin, M. Rodriguez, D. Thomas, R. T. Hay, J. L. Virelizier, and C. Dargemont. 1997. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110:369–378.
   PubMedGoogle Scholar
• Ashburner, B. P., S. D. Westerheide, and A. S. Baldwin, Jr. 2001. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:7065–7077.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Investig. 107:241–246.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–683.
   PubMed Web of Science ®Google Scholar
• Bates, P. W., and S. Miyamoto. 2004. Expanded Nuclear Roles for IκB s. Sci. STKE 254:pe48.
   Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736–2746.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167–170.
   PubMed Web of Science ®Google Scholar
• Bender, K., M. Gottlicher, S. Whiteside, H. J. Rahmsdorf, and P. Herrlich. 1998. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 17:5170–5181.
   PubMedGoogle Scholar
• Ben-Neriah, Y. 2002. Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3:20–26.
   PubMed Web of Science ®Google Scholar
• Bourke, E., E. J. Kennedy, and P. N. Moynagh. 2000. Loss of IκB-β is associated with prolonged NF-κB activity in human glial cells. J. Biol. Chem. 275:39996–40002.
   PubMedGoogle Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Budde, L. M., C. Wu, C. Tilman, I. Douglas, and S. Ghosh. 2002. Regulation of IκBβ expression in testis. Mol. Biol. Cell 13:4179–4194.
   PubMed Web of Science ®Google Scholar
• Chen, L., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653–1657.
   PubMed Web of Science ®Google Scholar
• Chen, Y., S. Vallee, J. Wu, D. Vu, J. Sondek, and G. Ghosh. 2004. Inhibition of NF-κB activity by IκBβ in association with κB-Ras. Mol. Cell. Biol. 24:3048–3056.
   PubMed Web of Science ®Google Scholar
• Chen, Y., J. Wu, and G. Ghosh. 2003. κB-Ras binds to the unique insert within the ankyrin repeat domain of IκBβ and regulates cytoplasmic retention of IκBβ × NF-κB complexes. J. Biol. Chem. 278:23101–23106.
   PubMed Web of Science ®Google Scholar
• Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor κB inhibitors IκBα and IκBβ. J. Exp. Med. 188:1055–1062.
   PubMedGoogle Scholar
• Cheshire, J. L., and A. S. Baldwin, Jr. 1997. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol. Cell. Biol. 17:6746–6754.
   PubMed Web of Science ®Google Scholar
• Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91:28–32.
   PubMed Web of Science ®Google Scholar
• Correa, R. G., V. Tergaonkar, J. K. Ng, I. Dubova, J. C. Izpisua-Belmonte, and I. M. Verma. 2004. Characterization of NF-κB/IκB proteins in zebra fish and their involvement in notochord development. Mol. Cell. Biol. 24:5257–5268.
   PubMed Web of Science ®Google Scholar
• DeLuca, C., H. Kwon, R. Lin, M. Wainberg, and J. Hiscott. 1999. NF-κB activation and HIV-1 induced apoptosis. Cytokine Growth Factor Rev. 10:235–253.
   PubMedGoogle Scholar
• DeLuca, C., L. Petropoulos, D. Zmeureanu, and J. Hiscott. 1999. Nuclear IκBβ maintains persistent NF-κB activation in HIV-1-infected myeloid cells. J. Biol. Chem. 274:13010–13016.
   PubMed Web of Science ®Google Scholar
• de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12:2773–2779.
   PubMed Web of Science ®Google Scholar
• DiDonato, J. A. 2000. Assaying for IκB kinase activity. Methods Enzymol. 322:393–400.
   PubMedGoogle Scholar
• Doi, T. S., M. W. Marino, T. Takahashi, T. Yoshida, T. Sakakura, L. J. Old, and Y. Obata. 1999. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. USA 96:2994–2999.
   PubMedGoogle Scholar
• Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953–961.
   PubMed Web of Science ®Google Scholar
• Feng, J., R. Tamaskovic, Z. Yang, D. P. Brazil, A. Merlo, D. Hess, and B. A. Hemmings. 2004. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J. Biol. Chem. 279:35510–35517.
   PubMed Web of Science ®Google Scholar
• Fenwick, C., S. Y. Na, R. E. Voll, H. Zhong, S. Y. Im, J. W. Lee, and S. Ghosh. 2000. A subclass of Ras proteins that regulate the degradation of IκB. Science 287:869–873.
   PubMed Web of Science ®Google Scholar
• Gao, H., Y. Sun, Y. Wu, B. Luan, Y. Wang, B. Qu, and G. Pei. 2004. Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways. Mol. Cell 14:303–317.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109:81–96.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–260.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D. 2003. The Re1/NF-κB/IκB signal transduction pathway and cancer. Cancer Treat. Res. 115:241–265.
   PubMedGoogle Scholar
• Grumont, R. J., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5:1321–1331.
   PubMedGoogle Scholar
• Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785–5799.
   PubMed Web of Science ®Google Scholar
• Guttridge, D. C., M. W. Mayo, L. V. Madrid, C.-Y. Wang, and A. S. Baldwin, Jr. 2000. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363–2366.
   PubMed Web of Science ®Google Scholar
• Harhaj, E. W., and S. C. Sun. 1999. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:7088–7095.
   PubMedGoogle Scholar
• Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18:2195–2224.
   PubMed Web of Science ®Google Scholar
• Hirano, F., M. Chung, H. Tanaka, N. Maruyama, I. Makino, D. D. Moore, and C. Scheidereit. 1998. Alternative splicing variants of IκBβ establish differential NF-κB signal responsiveness in human cells. Mol. Cell. Biol. 18:2596–2607.
   PubMed Web of Science ®Google Scholar
• Hoffmann, A., T. H. Leung, and D. Baltimore. 2003. Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22:5530–5539.
   PubMed Web of Science ®Google Scholar
• Huang, T. T., N. Kudo, M. Yoshida, and S. Miyamoto. 2000. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. USA 97:1014–1019.
   PubMed Web of Science ®Google Scholar
• Huxford, T., D. B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95:759–770.
   PubMed Web of Science ®Google Scholar
• Inan, M. S., R. Place, V. Tolmacheva, Q. S. Wang, A. K. Hubbard, D. W. Rosenberg, and C. Giardina. 2000. IκBβ-related proteins in normal and transformed colonic epithelial cells. Mol. Carcinogen. 29:25–36.
   PubMedGoogle Scholar
• Ito, C. Y., A. G. Kazantsev, and A. S. Baldwin, Jr. 1994. Three NF-κB sites in the IκB-α promoter are required for induction of gene expression by TNF-α. Nucleic Acids Res. 22:3787–3792.
   PubMedGoogle Scholar
• Jacobs, M. D., and S. C. Harrison. 1998. Structure of an IκBα/NF-κB complex. Cell 95:749–758.
   PubMed Web of Science ®Google Scholar
• Johnson, C., D. Van Antwerp, and T. J. Hope. 1999. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J. 18:6682–6693.
   PubMed Web of Science ®Google Scholar
• Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621–663.
   PubMed Web of Science ®Google Scholar
• Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301–310.
   PubMed Web of Science ®Google Scholar
• Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, P. H. Bhatt, C. H. Chen, C. A. Rosen, and C. L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341–2349.
   PubMed Web of Science ®Google Scholar
• Ladner, K. J., M. A. Caligiuri, and D. C. Guttridge. 2003. Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products. J. Biol. Chem. 278:2294–2303.
   PubMedGoogle Scholar
• Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12:5043–5049.
   PubMed Web of Science ®Google Scholar
• Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95:13012–13017.
   PubMed Web of Science ®Google Scholar
• Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725–734.
   PubMed Web of Science ®Google Scholar
• Liou, H. C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349–5359.
   PubMed Web of Science ®Google Scholar
• Makarov, S. S. 2001. NF-κB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 3:200–206.
   PubMedGoogle Scholar
• Malek, S., Y. Chen, T. Huxford, and G. Ghosh. 2001. IκBβ, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol. Chem. 276:45225–45235.
   PubMed Web of Science ®Google Scholar
• Malek, S., D. B. Huang, T. Huxford, S. Ghosh, and G. Ghosh. 2003. X-ray crystal structure of an IκBβ × NF-κB p65 homodimer complex. J. Biol. Chem. 278:23094–23100.
   PubMedGoogle Scholar
• McKinsey, T. A., Z. L. Chu, and D. W. Ballard. 1997. Phosphorylation of the PEST domain of IκBβ regulates the function of NF-κB/IκBβ complexes. J. Biol. Chem. 272:22377–22380.
   PubMedGoogle Scholar
• Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Pro. Natl. Acad. Sci. USA 91:5056–5060.
   PubMedGoogle Scholar
• Neurath, M. F., C. Becker, and K. Barbulescu. 1998. Role of NF-κB in immune and inflammatory responses in the gut. Gut 43:856–860.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523–527.
   PubMed Web of Science ®Google Scholar
• Richardson, J. C., A. M. Garcia Estrabot, and H. R. Woodland. 1994. XrelA, a Xenopus maternal and zygotic homologue of the p65 subunit of NF-κB. Characterisation of transcriptional properties in the developing embryo and identification of a negative interference mutant. Mech. Dev. 45:173–189.
   PubMedGoogle Scholar
• Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19:6367–6378.
   PubMed Web of Science ®Google Scholar
• Sun, S. C., J. Elwood, C. Beraud, and W. C. Greene. 1994. Human T-cell leukemia virus type I Tax activation of NF-κκB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377–7384.
   PubMedGoogle Scholar
• Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444–5449.
   PubMed Web of Science ®Google Scholar
• Tam, W. F., L. H. Lee, L. Davis, and R. Sen. 2000. Cytoplasmic sequestration of rel proteins by IκBα requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20:2269–2284.
   PubMedGoogle Scholar
• Tam, W. F., and R. Sen. 2001. IκB family members function by different mechanisms. J. Biol. Chem. 276:7701–7714.
   PubMedGoogle Scholar
• Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573–582.
   PubMed Web of Science ®Google Scholar
• Tran, K., M. Merika, and D. Thanos. 1997. Distinct functional properties of IκBα and IκBβ. Mol. Cell. Biol. 17:5386–5399.
   PubMedGoogle Scholar
• Verma, I. M., J. K. Stevenson, E. M. Schwartz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB /IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723–2735.
   PubMed Web of Science ®Google Scholar
• Wang, D., and A. S. Baldwin, Jr. 1998. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:29411–29416.
   PubMedGoogle Scholar
• Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9:3289–3297.
   PubMedGoogle Scholar
• Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243–252.
   PubMed Web of Science ®Google Scholar
• Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9:625–636.
   PubMed Web of Science ®Google Scholar
• Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661–671.
   PubMed Web of Science ®Google Scholar